Target Name: USP17L3
NCBI ID: G645836
Review Report on USP17L3 Target / Biomarker Content of Review Report on USP17L3 Target / Biomarker
USP17L3
Other Name(s): Ubiquitin thioesterase 17-like protein 3 | USP17F | Deubiquitinating enzyme 17-like protein 3 | Ubiquitin specific peptidase 17-like 3 | ubiquitin thioesterase 17-like protein 3 | Ubiquitin-specific-processing protease 17-like protein 3 | U17L3_HUMAN | ubiquitin-specific-processing protease 17-like protein 3 | ubiquitin specific peptidase 17-like 3 | deubiquitinating enzyme 17-like protein 3 | Dubiquitinating enzyme 17-like protein 3 | USP17B | ubiquitin specific peptidase 17 like family member 3 | Ubiquitin carboxyl-terminal hydrolase 17-like protein 3 | Ubiquitin specific peptidase 17 like family member 3

USP17L3: A Potential Drug Target and Biomarker

USP17L3, also known as Ubiquitin thioesterase 17-like protein 3, is a protein that plays a crucial role in the regulation of protein degradation in the body. It is a member of the ubiquitin family of proteins, which are known for their role in regulating protein stability and stability-related processes in a variety of cellular processes. USP17L3 has been shown to be involved in a wide range of cellular processes, including cell signaling, DNA damage repair, and inflammation.

One of the key functions of USP17L3 is its role in protein degradation. ubiquitin is a protein that can be covalently attached to a wide variety of target proteins, where it can play a number of different roles in regulating protein stability and stability-related processes. USP17L3 is involved in the degradation of a number of different proteins, including histone H3, Dangji M1, and the protein known as T-cell antigen 4 (TCA4).

In addition to its role in protein degradation, USP17L3 has also been shown to be involved in a number of other cellular processes. For example, it has been shown to be involved in the regulation of cell signaling, both in the signaling pathway known as the TOR pathway and in the signaling pathway known as the PI3K/Akt pathway. USP17L3 has also been shown to be involved in the regulation of DNA damage repair, as well as in the regulation of inflammation.

Given its involvement in a wide range of cellular processes, USP17L3 is a potential drug target. Many diseases, including cancer, are characterized by the dysregulation of protein stability and stability-related processes. USP17L3 has been shown to play a role in the regulation of protein stability and stability-related processes, which suggests that it may be a useful target for the development of new therapies.

In addition to its potential as a drug target, USP17L3 is also a potential biomarker. The levels of USP17L3 have been shown to be elevated in a variety of cancer types, including breast cancer, lung cancer, and colorectal cancer. This suggests that USP17L3 may be a useful biomarker for the diagnosis and treatment of these cancers.

Overall, USP17L3 is a protein that plays a crucial role in the regulation of protein stability and stability-related processes in the body. Its potential as a drug target and biomarker makes it an attractive target for further research in the field of cancer and other diseases .

Protein Name: Ubiquitin Specific Peptidase 17 Like Family Member 3

Functions: Deubiquitinating enzyme that removes conjugated ubiquitin from specific proteins to regulate different cellular processes that may include cell proliferation, progression through the cell cycle, apoptosis, cell migration, and the cellular response to viral infection

The "USP17L3 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about USP17L3 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

USP17L5 | USP17L6P | USP17L7 | USP17L8 | USP17L9P | USP18 | USP19 | USP2 | USP2-AS1 | USP20 | USP21 | USP22 | USP24 | USP25 | USP26 | USP27X | USP27X-DT | USP28 | USP29 | USP3 | USP3-AS1 | USP30 | USP30-AS1 | USP31 | USP32 | USP32P1 | USP32P2 | USP32P3 | USP33 | USP34 | USP35 | USP36 | USP37 | USP38 | USP39 | USP4 | USP40 | USP41 | USP42 | USP43 | USP44 | USP45 | USP46 | USP46-DT | USP47 | USP48 | USP49 | USP5 | USP50 | USP51 | USP53 | USP54 | USP6 | USP6NL | USP6NL intronic transcript 1 (non-protein coding), transcript variant 1 | USP7 | USP8 | USP8P1 | USP9X | USP9Y | USPL1 | UST | UTF1 | UTP11 | UTP14A | UTP14C | UTP15 | UTP18 | UTP20 | UTP23 | UTP25 | UTP3 | UTP4 | UTP6 | UTRN | UTS2 | UTS2B | UTS2R | UTY | UVRAG | UVSSA | UXS1 | UXT | UXT-AS1 | VAC14 | Vacuolar H+ ATPase | VAMP1 | VAMP2 | VAMP3 | VAMP4 | VAMP5 | VAMP7 | VAMP8 | VANGL1 | VANGL2 | VAPA | VAPB | VARS1 | VARS2 | Vascular endothelial growth factor receptor (VEGFR)